Skip to content

Clinical trials

Phase 3 Neoplasms trials in South Africa

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 3 Country / region: South Africa Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20051
20072
20082
20092
20111
20121
20131
20171
20191
20204
20222
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting6
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
Sanofi4
Amgen3
Genmab3
Bayer2
Pfizer2
AstraZeneca1
Hoffmann-La Roche1
Novartis Pharmaceuticals1
R-Pharm1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms22
Prostatic Neoplasms4
Breast Neoplasms3
Lymphoma, Non-Hodgkin3
Neoplasm Metastasis3
Carcinoma, Non-Small-Cell Lung2
Lymphoma2
Lymphoma, Follicular2
Primary Myelofibrosis2
Recurrence2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.